On the preferential release of mesolimbic dopamine by amphetamine
Di Chiara, G.
Neuropsychopharmacology Official Publication of the American College of Neuropsychopharmacology 5(4): 243-247
1991
ISSN/ISBN: 0893-133X PMID: 1804162 Document Number: 377353
Document emailed within 1 workday
Related Documents
Kuczenski, R. 1980: Amphetamine-haloperidol interactions on striatal and mesolimbic tyrosine hydroxylase activity and dopamine metabolism Journal of Pharmacology and Experimental Therapeutics 215(1): 135-142Jacocks, H.M.; Cox, B.M. 1992: Serotonin-stimulated release of [3H]dopamine via reversal of the dopamine transporter in rat striatum and nucleus accumbens: a comparison with release elicited by potassium, N-methyl-D-aspartic acid, glutamic acid and D-amphetamine Journal of Pharmacology and Experimental Therapeutics 262(1): 356-364
Parker, E.M.; Cubeddu, L.X. 1986: Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores Journal of Pharmacology and Experimental Therapeutics 237(1): 179-192
Chiueh, C.C.; Moore, K.E. 1975: D-amphetamine-induced release of "newly synthesized" and "stored" dopamine from the caudate nucleus in vivo Journal of Pharmacology and Experimental Therapeutics 192(3): 642-653
Kamal, L.A.; Arbilla, S.; Langer, S.Z. 1981: Presynaptic modulation of the release of dopamine from the rabbit caudate nucleus: differences between electrical stimulation, amphetamine and tyramine Journal of Pharmacology and Experimental Therapeutics 216(3): 592-598
Kalivas, P. 1985: Substance P modulation of the mesolimbic dopamine system Progress in Clinical and Biological Research 192: 403-408
Hoffmann, I.S.; Talmaciu, R.K.; Cubeddu, L.X. 1986: Interactions between endogenous dopamine and dopamine agonists at release modulatory receptors: multiple effects of neuronal uptake inhibitors on transmitter release Journal of Pharmacology and Experimental Therapeutics 238(2): 437-446
Kalivas, P.W. 1984: Evidence for interactions of endogenous peptides with the mesolimbic dopamine system Psychopharmacology Bulletin 20(3): 354-357
Wagner, G.C.; Ricaurte, G.A.; Johanson, C.E.; Schuster, C.R.; Seiden, L.S. 1980: Amphetamine induces depletion of dopamine and loss of dopamine uptake sites in caudate Neurology 30(5): 547-550
Kuczenski, R.; Segal, D.S. 1992: Differential effects of amphetamine and dopamine uptake blockers (cocaine, nomifensine) on caudate and accumbens dialysate dopamine and 3-methoxytyramine Journal of Pharmacology and Experimental Therapeutics 262(3): 1085-1094
Wustmann, C.; Rudolph, E.; Schwipper, U.; Ranacher, B.; Fischer, H.D.; Schmidt, J. 1982: Effect of nootropic drugs on the dopamine release and dopamine uptake in structures of the rat striatum Acta Biologica et Medica Germanica 41(6): 575-579
Dwoskin, L.P.; Zahniser, N.R. 1986: Robust modulation of [3H]dopamine release from rat striatal slices by D-2 dopamine receptors Journal of Pharmacology and Experimental Therapeutics 239(2): 442-453
Baker, W.W.; Zivanovic, D.; Malseed, R.T. 1976: Tremorogenic effects of intracaudate d-amphetamine and their suppression by dopamine Archives Internationales de Pharmacodynamie et de Therapie 223(2): 271-281
Jakubowska-Doğru, E. 1999: Modification of avoidance responding by amphetamine and dopamine receptor antagonists Polish Journal of Pharmacology 51(4): 301-309
Fischer, J.F.; Cho, A.K. 1976: Properties of dopamine efflux from rat striatal tissue caused by amphetamine and p-hydroxyamphetamine Proceedings of the Western Pharmacology Society 19: 179-182
Felt, V.; Stajnerová, M. 1970: Preferential role of oleic acid in the deposition and release of depot fat in man Casopis Lekaru Ceskych 109(43): 1016-1017
Helmeste, D.M.; Seeman, P. 1983: Genetic differences in brain dopamine receptors and amphetamine response: possible model for hyperkinetic children Progress in Clinical and Biological Research 135: 401-403
Antelman, S.M.; Chiodo, L.A. 1981: Dopamine autoreceptor subsensitivity: a mechanism common to the treatment of depression and the induction of amphetamine psychosis Biological Psychiatry 16(8): 717-727
Lotharius, J.; O'Malley, K.L. 2001: Role of mitochondrial dysfunction and dopamine-dependent oxidative stress in amphetamine-induced toxicity Annals of Neurology 49(1): 79-89
Steketee, J.D.; Kalivas, P.W. 1992: Microinjection of the D2 agonist quinpirole into the A10 dopamine region blocks amphetamine-, but not cocaine-stimulated motor activity Journal of Pharmacology and Experimental Therapeutics 261(2): 811-818